N/A
Completed N=200
Telephonic Contact and Subsequent Physical Follow up Treated Lung Cancer Patients
Source: ClinicalTrials.gov NCT01133067 ↗Enrolled (actual)
200
Serious AEs
0.0%
Results posted
Aug 2018
Primary outcomePrimary: Concurrence Between the Telephonic Interview and the Physician Assessment — 0.64 probability
Summary
Does the routine clinical practice of follow up after primary treatment in lung cancer patients has any utility.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Concurrence Between the Telephonic Interview and the Physician Assessment |
0.64 | — |
| SECONDARY Cost Analysis |
5117.10; 3079.06 | — |
Eligibility Criteria
Inclusion Criteria
- All patients of lung cancer treated with a radical aim (e.g surgery, Chemoradiation, surgery followed by adjuvant treatment or any other combination)
- Patients should have completed radical /adjuvant treatment, if any
- Patients of both SCLC and NSCLC
- Patients with at least two telephone numbers (landline/mobile/both)
- Patients willing to participate
Exclusion Criteria
- All patients for palliative intention
- Patients with less than two contact telephone numbers -
Data sourced from ClinicalTrials.gov (NCT01133067). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.